Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xiangya Hospital Of Central South University

Clinical trials sponsored by Xiangya Hospital Of Central South University, explained in plain language.

Trials to join now! 1 Not yet recruiting 5 Not yet finished but already full! 1 Completed 2

New triple therapy targets hard-to-treat liver cancer

Disease control ENROLLING_BY_INVITATION

This early-phase study tests whether adding two drugs (JS014 and toripalimab) to a standard procedure called TACE can safely control liver cancer that cannot be removed by surgery. About 20 adults with unresectable hepatocellular carcinoma will receive the combination. The main g…

Phase: PHASE1 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control

Last updated May 01, 2026 16:01 UTC